Javascript must be enabled to continue!
Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas
View through CrossRef
C. Christov, H. Adle‐Biassette, C. Le Guerinel, S. Natchev and R. K. Gherardi (1998) Neuropathology and Applied Neurobiology24, 29–35Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomasVascular endothelial growth factor (VEGF) appears to be implicated in tumour angiogenesis. In the present study immunohistochemical expression of VEGF was evaluated in 34 oligodendrogliomas (13 grade II, 21 grade III [WHO]). VEGF immunoreactivity was found in 31 of 34 cases. Expression of VEGF was observed in endothelial cells and some vascular smooth muscle cells, but not in neoplastic oligodendrocytes. Vessel counts, percentages of VEGF‐positive vessels and vessels with vascular endothelial proliferation were assessed. The degree of VEGF labelling and vascular‐endothelial proliferation in each vessel were evaluated using a 3 degree intensity score. Expression of VEGF was higher in grade III than in grade II oligodendrogliomas as assessed by percentage of VEGF positive vessels (55.8 ± 29.2% vs 17.0 ± 19.0% [P < 0.001]) and by VEGF immunostaining intensity (1.90 ± 0.60 vs 0.90 ± 0.40 [P < 0.001]). VEGF expression did not correlate with vessel density. Intensity of VEGF expression correlated positively with that of vascular‐endothelial proliferation in grade III tumours (r=+0.47 [P < 0.05]). The percentage of VEGF positive vessels showed some degree of positive correlation with the percentage of vessels showing vascular‐endothelial proliferation (r=+408 [P < 0.10]). Within individual grade III tumours 67.5 ± 29.6% of all vessels with vascular‐endothelial proliferation were VEGF‐positive and 31.0 ± 20.5% of all VEGF‐positive vessels showed no evidence of vascular‐endothelial proliferation. We conclude that (i) expression of VEGF is observed in the vasculature of oligodendrogliomas; (ii) marked expression of VEGF is observed in grade III oligodendrogliomas; (iii) VEGF may be one of the interrelated causative stimuli acting in concert to induce vascular‐endothelial proliferation.
Title: Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas
Description:
C.
Christov, H.
Adle‐Biassette, C.
Le Guerinel, S.
Natchev and R.
K.
Gherardi (1998) Neuropathology and Applied Neurobiology24, 29–35Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomasVascular endothelial growth factor (VEGF) appears to be implicated in tumour angiogenesis.
In the present study immunohistochemical expression of VEGF was evaluated in 34 oligodendrogliomas (13 grade II, 21 grade III [WHO]).
VEGF immunoreactivity was found in 31 of 34 cases.
Expression of VEGF was observed in endothelial cells and some vascular smooth muscle cells, but not in neoplastic oligodendrocytes.
Vessel counts, percentages of VEGF‐positive vessels and vessels with vascular endothelial proliferation were assessed.
The degree of VEGF labelling and vascular‐endothelial proliferation in each vessel were evaluated using a 3 degree intensity score.
Expression of VEGF was higher in grade III than in grade II oligodendrogliomas as assessed by percentage of VEGF positive vessels (55.
8 ± 29.
2% vs 17.
0 ± 19.
0% [P < 0.
001]) and by VEGF immunostaining intensity (1.
90 ± 0.
60 vs 0.
90 ± 0.
40 [P < 0.
001]).
VEGF expression did not correlate with vessel density.
Intensity of VEGF expression correlated positively with that of vascular‐endothelial proliferation in grade III tumours (r=+0.
47 [P < 0.
05]).
The percentage of VEGF positive vessels showed some degree of positive correlation with the percentage of vessels showing vascular‐endothelial proliferation (r=+408 [P < 0.
10]).
Within individual grade III tumours 67.
5 ± 29.
6% of all vessels with vascular‐endothelial proliferation were VEGF‐positive and 31.
0 ± 20.
5% of all VEGF‐positive vessels showed no evidence of vascular‐endothelial proliferation.
We conclude that (i) expression of VEGF is observed in the vasculature of oligodendrogliomas; (ii) marked expression of VEGF is observed in grade III oligodendrogliomas; (iii) VEGF may be one of the interrelated causative stimuli acting in concert to induce vascular‐endothelial proliferation.
Related Results
Conjugate vaccines targeting the tumor vasculature
Conjugate vaccines targeting the tumor vasculature
Cancer cells acquire critical hallmarks which eventually facilitate the formation of malignant tumors. In this thesis, we highlighted two important hallmarks, the induction of angi...
Vascular Endothelial Growth Factor Variants (936C/T, 634C/G, 2578A/C) and Their Genotype–Haplotype Association with Recurrent Implantation Failure in Infertile Women: A Single-Center Analytical Study
Vascular Endothelial Growth Factor Variants (936C/T, 634C/G, 2578A/C) and Their Genotype–Haplotype Association with Recurrent Implantation Failure in Infertile Women: A Single-Center Analytical Study
Background: Vascular Endothelial Growth Factor (VEGF) is a key regulator in angiogenesis and contributes to a successful implantation. The current study has the following objective...
Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A
Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A
AbstractDuring bone formation and fracture healing there is a cross-talk between endothelial cells and osteoblasts. We previously showed that vascular endothelial growth factor A (...
Hypoxia Induced Heparan Sulfate Primes the Extracellular Matrix for Endothelial Cell Recruitment by Facilitating VEGF-Fibronectin Interactions
Hypoxia Induced Heparan Sulfate Primes the Extracellular Matrix for Endothelial Cell Recruitment by Facilitating VEGF-Fibronectin Interactions
Vascular endothelial growth factor-A (VEGF) is critical for the development, growth, and survival of blood vessels. Retinal pigmented epithelial (RPE) cells are a major source of V...
Targeting regulation of VEGF by BPTF in Non-Small Cell Lung Cancer and its potential clinical significance
Targeting regulation of VEGF by BPTF in Non-Small Cell Lung Cancer and its potential clinical significance
Abstract
Purpose
VEGF facilitates the formation of tumor angiogenesis, and bevacizumab targeting VEGF is used in anti-tumor therapy. It’s meaningful to clarify the upstrea...
Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma
Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma
Tumor cells express vascular endothelial growth factor (VEGF) that can activate VEGF receptors (VEGFRs) on or within tumor cells to promote growth in an angiogenesis-independent fa...
Prospective role of VEGF in the association between periodontitis and psoriasis: a scoping review
Prospective role of VEGF in the association between periodontitis and psoriasis: a scoping review
Introduction: Increasing evidence suggests an association between periodontitis and psoriasis. Both diseases share immunoinflammatory mechanisms and involve angiogenesis mediated b...
Role of vascular endothelial growth factor in tuberculous meningitis
Role of vascular endothelial growth factor in tuberculous meningitis
INTRODUCTION:
The status of vascular endothelial-derived growth factor (VEGF) in the pathogenesis of tuberculous meningitis (TBM) remains far from clear. We prospective...

